Last Chance To Influence Changes To NICE Methods & Processes In England
Executive Summary
Companies selling gene therapies and other high-cost, long-term treatments may be disappointed but unsurprised to learn that NICE will not immediately introduce any change to discount rates, which are used in health technology appraisals to better understand the long-term costs and benefits.
You may also be interested in...
Search Over For New Chief For England’s NICE
NICE, which is seen as a global leader when it comes to assessing the clinical and cost effectiveness of health care products, has appointed Samantha Roberts as its third chief executive in its over 20-year history.
England’s NICE To Find New Chief As Leng Announces Retirement
The top job at the National Institute for Health and Care Excellence has been described as one of the most challenging and potentially controversial roles in British public life.
England’s NICE To Find New Chief As Leng Announces Retirement
The top job at the National Institute for Health and Care Excellence has been described as one of the most challenging and potentially controversial roles in British public life.